Navigation Links
Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
Date:10/8/2007

ANN ARBOR, Mich., Oct. 8 /PRNewswire-FirstCall/ -- In a study published in the Journal of Women's Health, researchers from the Centers for Disease Control and Prevention and Thomson Healthcare (NYSE: TOC; TSK: TOC) found a distinct pattern of medical signs and symptoms that occurred prior to the detection of ovarian cancer.

According to the study, the conditions patients experienced before an ovarian cancer diagnosis included abdominal pain, urinary tract conditions, menopausal disorders, female genital symptoms, and gastrointestinal symptoms. These symptoms were most pronounced in the 30-90 days prior to diagnosis.

To make this determination, researchers analyzed medical claims from 920 patients diagnosed with ovarian cancer and tracked the symptoms those patients experienced prior to diagnosis. These results were compared with claims data for 2,760 women without ovarian cancer matched on age, geographic region, Medicare eligibility, and health plan type.

Five conditions were identified as being possibly related to ovarian cancer because they were reported significantly more frequently by women diagnosed with the cancer than they were in the comparison group. While all symptoms were reported among women with and without ovarian cancer, the rate of these symptoms was higher, and continued to increase, beginning 90 days prior to diagnosis. Abdominal pain was most frequently linked to a subsequent ovarian cancer diagnosis, with 83 percent of women in the ovarian cancer group recording abdominal pain within 30 days of diagnosis in contrast to fewer than two percent in the comparison group.

Other symptoms more frequently recorded for the ovarian cancer group included female genital symptoms, which w
'/>"/>

SOURCE Thomson Healthcare
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Iron supplementation for a common side effect
3. Genetic Breakthrough in Common Eye Problem
4. Common Cold Found to Fight Cancer Cells
5. Side Effects Of Some Common Drugs
6. E. coli strains resistant to a common antibiotic
7. Gastrointestinal ills more common in diabetics
8. Toxic effects common with AIDS treatments
9. Common contraception
10. Drooping eyelids more common in men
11. Unnatural death common in mentally ill

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... EDINA,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmo...Butachiropractorcanalsogivepatientsthehelptheyneed...ereyourjaw(mandible)contacts/connectswithyourskull...tedwithTMJdysfunctionarepainwithchewing,clickingor...mTMJdysfunctionincluding:headaches,fatigue,sleepdi...
(Date:11/25/2009)... TORONTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,...ualizationsoftwarelaunchesasuiteofnewleadingedgecl...wareplatformatthisyear,sRadiologicalSocietyofNorth...009(Booth5800,HallA).Theapplicationsleveragetheuni...izedMRIimagingcoilsandsupportmultipleimagingmodali...
(Date:11/25/2009)... SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQua...nter Spare the Air Alert forThursday...irelogsoranyothersolidfuel,bothindoorsandoutdoors....airqualitytomorrow,"saidJackBroadbent,executiveoff...orespectthehealthoftheirneighborsandfellowcommunit...
(Date:11/25/2009)...ortuitous discovery that grew out of a collaborati...entially offer hope to the nearly 10 million Ameri... , Also known as hardening of the arteries, p...rculatory problem in which narrowed arteries reduc...ered a red flag for vascular disease, heart attack...
(Date:11/25/2009)... Evaluation and treatment clinic... Woodstock (Vocus) November 25, 2009 -- Centeg... vaccines and H1N1 vaccine shots at four Centegra ...er shipment of vaccine has arrived. The clinics ar... and McHenry and will be open as follows: , &n...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...wn to have a genetic predisposition. //This study ... DNA double helix. Collaborated Research is b...de Hospital campus of The Feinstein Institute for ... that vary dramatically in symptoms and severity a...
...greement to deliver a fast, efficient new electron...ve as a win for patients and doctors alike. T...irst organisation to sign up to deliver the new sy...mmittee on Information Technology, Dr Peter Garcia...
...and disappointment on hearing the news about a Lib...ences on five Bulgarian nurses and one Palestinian...reds of children with HIV. George Bush has exp...urses would be fully supported by him. The US ...
...IDF) Diabetes Atlas released early December in Sou...hest in India.// But China overtakes India in the ...T). The Atlas, third in a series that began i... is predicted to increase dramatically over the ne...
...read to many different sites often do not have man...to tolerate the doses of treatment they would need... Hope and St. Jude Children's Research Hospital ma...trate chemotherapeutic drugs predominately at tumo...
... research centre is being planned at the Pune-base...eat diseases//, a general says. "Stem cell ther...edicine. It will be the futuristic treatment repla...e disease and various other diseases can be cured,...
Other Medicine News:Health News:Research on Bipolar Disorder Launched 2Health News:Researchers Find Stem-cell Therapy Effective in Targeting Metastatic Cancer 2Health News:Military College to Set Up Stem Cell Research Centre 2
(Date:11/25/2009)...ire/--Reportlinker.comannouncesthatanewmarketresea...nagement-GlobalTrends ,, http://www.reportli...html ,, Widespreadavailabilityofgenericdrugs,e...rugshaveacceleratedthepaceofgrowthinthepainmanagem...recontinuetoshapedemandforservices,drugsanddevices...
(Date:11/25/2009)...NEY,Nov.25/PRNewswire-FirstCall/--HeartWareInterna...orandprovideroflessinvasive,miniaturizedcirculator...dvancedheartfailure,todayannouncedthatitisschedule...affrayHealthCareConferenceat8:00amESTonWednesday,D...PalaceHotel,December1-2. ,, AlivewebcastoftheCo...
(Date:11/24/2009)...wswire/-- ,, WHAT:RomHoubens,aBelgianmanthought...wasactuallyfullyconsciousandawakeduringthattimeand...oxEyeMaxwasfeaturedinthesegmenttoillustratehowpeop...communication. ,, WHEN:GoodMorningAmerica-- Tue...ch.com ,, WHO:RomHoubenswasanengineeringstu...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 1InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 2InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 3InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 4InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 5InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 6InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 7InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 8InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 9InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 10InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 11InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 12InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 13InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 14InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 15OncoGenex Reports Second Quarter 2009 Financial Results 13426 1OncoGenex Reports Second Quarter 2009 Financial Results 13426 2OncoGenex Reports Second Quarter 2009 Financial Results 13426 3OncoGenex Reports Second Quarter 2009 Financial Results 13426 4OncoGenex Reports Second Quarter 2009 Financial Results 13426 5OncoGenex Reports Second Quarter 2009 Financial Results 13426 6OncoGenex Reports Second Quarter 2009 Financial Results 13426 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 8
OCUFLOX® 5 mL
ALPHAGAN® 5 mL
ACULAR® 5 mL
ACULAR® 10 mL
Medicine Products: